Skip to content

Brian Adams, Chief Legal Officer at Kymera Therapeutics, sold KYMR on Sep 4, 2026

Data as of Oct 16

▼ SELL$251K2,137 shares at $117.57Brian Adams Chief Legal OfficerKYMR Kymera Therapeutics, Inc.
Watch KYMR
Traded
Sep 4, 2026
Disclosed
Sep 4, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Brian Adams, Chief Legal Officer at Kymera Therapeutics, sold KYMR on Sep 4, 2026TRADEDDISCLOSED
KYMRSimilar stocks (XLV — its sector index fund), rebased to KYMR's price on the disclosure day
KYMR since disclosure
−10.7%
after the sale
Similar stocks (XLV) since disclosure
+3.1%
XLV — its sector index fund

Change in closing price from Sep 4, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLBrian Adams Chief Legal OfficerKYMR Kymera Therapeutics, Inc.$140Kdisclosed Sep 4 · filed the same day
  2. ▼ SELLBrian Adams Chief Legal OfficerKYMR Kymera Therapeutics, Inc.$353Kdisclosed Sep 4 · filed the same day

See every trade on KYMR →